Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence

LOGIN

REGISTER

SUBSCRIBE


Forgot your login? GET HELP

​​

Tardive dyskinesia (TD) is a condition of potentially irreversible abnormal involuntary movements associated with dopamine receptor blocking agents, such as antipsychotics. While prevention is the best strategy, it is not always possible. This report outlines strategies to reduce TD symptoms, including the use of the FDA-approved treatment options (valbenazine and deutetrabenazine).

See the entire activity.​​​​​​

J Clin Psychiatry 2020;81(6):NU19047BR3C

https://doi.org/10.4088/JCP.NU19047BR3C